Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
Therapy of patients with pemphigus vulgaris with systemic corticosteroids may not be effective enough or lead to the development of severe adverse events that make it necessary to reduce the dose of corticosteroid. In such cases, it is possible to use the immunosuppressants. The literature review an...
Saved in:
Main Authors: | Vadim V. Chikin, Arfenya E. Karamova |
---|---|
Format: | Article |
Language: | English |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2024-12-01
|
Series: | Vestnik Dermatologii i Venerologii |
Subjects: | |
Online Access: | https://vestnikdv.ru/jour/article/viewFile/16808/pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of modern techniques and analysis of patient outcomes with benign familial pemphigus Gougereau–Haley–Haley
by: Marianna B. Drozhdina, et al.
Published: (2024-12-01) -
Direct immunofluorescence (DIF) versus immunohistochemical (IHC) staining of complements and immunoglobulins (Ig) in pemphigus group
by: Deepika Rana, et al.
Published: (2024-04-01) -
Comparison of scores for predictability of corticosteroid failure in patients with acute severe ulcerative colitis
by: Knežević Milica A., et al.
Published: (2024-01-01) -
Immunosuppressants in modern approaches to treatment of inflammatory bowel diseases
by: O. B. Schukina, et al.
Published: (2013-05-01) -
Using Dose-Effect Relationship for Optimising Systemic Corticosteroid Dosage in Treatment of Inflammatory Bowel Diseases
by: O. P. Alekseeva, et al.
Published: (2020-12-01)